Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth

Abstract

Induction of haem oxygenase-1 (HO-1) as well as nitric oxide (NO) biosynthesis during tumour growth was investigated in an experimental solid tumour model (AH136B hepatoma) in rats. An immunohistochemical study showed that the inducible isoform of NO synthase (iNOS) was localized in monocyte-derived macrophages, which infiltrated interstitial spaces of solid tumour, but not in the tumour cells. Excessive production of NO in the tumour tissue was unequivocally verified by electron spin resonance spectroscopy. Tumour growth was moderately suppressed by treatment with either Nomega-nitro-L-arginine methyl ester (L-NAME) or S-methylisothiourea sulphate (SMT). In contrast, HO-1 was found only in tumour cells, not in macrophages, by in situ hybridization for HO-1 mRNA. HO-1 expression in AH136B cells in culture was strongly enhanced by an NO (NO+) donor S-nitroso-N-acetyl penicillamine. HO-1 mRNA expression in the solid tumour in vivo decreased significantly after treatment with low doses of NOS inhibitors such as L-NAME and SMT (6-20 mg kg(-1)). However, the level of HO-1 mRNA in the solid tumour treated with higher doses of NOS inhibitor was similar to that of the solid tumour without NOS inhibitor treatment. Strong induction of HO-1 was also observed in solid tumours after occlusion or embolization of the tumour-feeding artery, indicating that ischaemic stress which may involve oxidative stress triggers HO-1 induction in the solid tumour. Lastly, it is of great importance that an HO inhibitor, zinc protoporphyrin IX injected intra-arterially to the solid tumour suppressed the tumour growth to a great extent. In conclusion, HO-1 expression in the solid tumour may confer resistance of tumour cells to hypoxic stress as well as to NO-mediated cytotoxicity.

References 47

1. 1.

   Akaike T., Inoue K., Okamoto T., Nishino H., Otagiri M., Fujii S., Maeda H. Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent. J Biochem. 1997;122(2):459-466.

   Not in our library10.1093/oxfordjournals.jbchem.a021774

2. 2.

   Andrade S. P., Hart I. R., Piper P. J. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol. 1992;107(4):1092-1095.

   Not in our library10.1111/j.1476-5381.1992.tb13412.x

3. 3.

   Bastian N. R., Yim C. Y., Hibbs J. B., Samlowski W. E. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets. J Biol Chem. 1994;269(7):5127-5131.

   Not in our library

4. 4.

   Buttery L. D., Springall D. R., Andrade S. P., Riveros-Moreno V., Hart I., Piper P. J., Polak J. M. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J Pathol. 1993;171(4):311-319.

   Not in our library10.1002/path.1711710412

5. 5.

   Cobbs C. S., Brenman J. E., Aldape K. D., Bredt D. S., Israel M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995;55(4):727-730.

   Not in our library

6. 6.

   Doi K., Akaike T., Horie H., Noguchi Y., Fujii S., Beppu T., Ogawa M., Maeda H. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer. 1996;77(8 Suppl):1598-1604.

   Not in our library10.1002/(sici)1097-0142(19960415)77:8<1598::aid-cncr27>3.0.co;2-u

7. 7.

   Goodman A. I., Choudhury M., da Silva J. L., Jiang S., Abraham N. G. Quantitative measurement of heme oxygenase-1 in the human renal adenocarcinoma. J Cell Biochem. 1996;63(3):342-348.

   Not in our library10.1002/(sici)1097-4644(19961201)63:3<342::aid-jcb9>3.0.co;2-x

8. 8.

   Hara E., Takahashi K., Tominaga T., Kumabe T., Kayama T., Suzuki H., Fujita H., Yoshimoto T., Shirato K., Shibahara S. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem Biophys Res Commun. 1996;224(1):153-158.

   Not in our library10.1006/bbrc.1996.0999

9. 9.

   Hibbs J. B., Taintor R. R., Vavrin Z., Rachlin E. M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157(1):87-94.

   Not in our library10.1016/s0006-291x(88)80015-9

10. 10.

    Jenkins D. C., Charles I. G., Thomsen L. L., Moss D. W., Holmes L. S., Baylis S. A., Rhodes P., Westmore K., Emson P. C., Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A. 1995;92(10):4392-4396.

    Not in our library10.1073/pnas.92.10.4392

11. 11.

    Kim Y. M., Bergonia H. A., Müller C., Pitt B. R., Watkins W. D., Lancaster J. R. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem. 1995;270(11):5710-5713.

    Not in our library10.1074/jbc.270.11.5710

12. 12.

    Kim Y. M., Bergonia H., Lancaster J. R. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett. 1995;374(2):228-232.

    Not in our library10.1016/0014-5793(95)01115-u

13. 13.

    Lala P. K., Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev. 1998;17(1):91-106.

    Not in our library10.1023/a:1005960822365

14. 14.

    Lee T. C., Ho I. C. Expression of heme oxygenase in arsenic-resistant human lung adenocarcinoma cells. Cancer Res. 1994;54(7):1660-1664.

    Not in our library

15. 15.

    Leibovich S. J., Polverini P. J., Fong T. W., Harlow L. A., Koch A. E. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A. 1994;91(10):4190-4194.

    Not in our library10.1073/pnas.91.10.4190

16. 16.

    Lepoivre M., Flaman J. M., Bobé P., Lemaire G., Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem. 1994;269(34):21891-21897.

    Not in our library

17. 17.

    Maeda H., Noguchi Y., Sato K., Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res. 1994;85(4):331-334.

    Not in our library10.1111/j.1349-7006.1994.tb02362.x

18. 18.

    Maines M. D., Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci U S A. 1974;71(11):4293-4297.

    Not in our library10.1073/pnas.71.11.4293

19. 19.

    Maines M. D., Kappas A. Prematurely evoked synthesis and induction of delta-aminolevulinate synthetase in neonatal liver. Evidence for metal ion repression of enzyme formation. J Biol Chem. 1978;253(7):2321-2326.

    Not in our library

20. 20.

    Maines M. D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517-554.

    Not in our library10.1146/annurev.pharmtox.37.1.517

21. 21.

    Maines M. D. Zinc. protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta. 1981;673(3):339-350.

    Not in our library10.1016/0304-4165(81)90465-7

22. 22.

    Matsumura Y., Kimura M., Yamamoto T., Maeda H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res. 1988;79(12):1327-1334.

    Not in our library10.1111/j.1349-7006.1988.tb01563.x

23. 23.

    Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002-2012.

    Not in our library10.1056/nejm199312303292706

24. 24.

    Nakano S., Matsukado K., Black K. L. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res. 1996;56(17):4027-4031.

    Not in our library

25. 25.

    Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys. 1997;342(2):261-274.

    Not in our library10.1006/abbi.1997.0127

26. 26.

    Prabhakar N. R., Dinerman J. L., Agani F. H., Snyder S. H. Carbon monoxide: a role in carotid body chemoreception. Proc Natl Acad Sci U S A. 1995;92(6):1994-1997.

    Not in our library10.1073/pnas.92.6.1994

27. 27.

    Setoguchi K., Takeya M., Akaike T., Suga M., Hattori R., Maeda H., Ando M., Takahashi K. Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am J Pathol. 1996;149(6):2005-2022.

    Not in our library

28. 28.

    Shibahara S., Müller R., Taguchi H., Yoshida T. Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci U S A. 1985;82(23):7865-7869.

    Not in our library10.1073/pnas.82.23.7865

29. 29.

    Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043-1046.

    Not in our library10.1126/science.3029864

30. 30.

    Stuehr D. J., Griffith O. W. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol. 1992;65:287-346.

    Not in our library10.1002/9780470123119.ch8

31. 31.

    Suematsu M., Goda N., Sano T., Kashiwagi S., Egawa T., Shinoda Y., Ishimura Y. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest. 1995;96(5):2431-2437.

    Not in our library10.1172/jci118300

32. 32.

    Suzuki K., Hayashi N., Miyamoto Y., Yamamoto M., Ohkawa K., Ito Y., Sasaki Y., Yamaguchi Y., Nakase H., Noda K. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 1996;56(13):3004-3009.

    Not in our library

33. 33.

    Takahashi K., Hara E., Suzuki H., Sasano H., Shibahara S. Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors. J Neurochem. 1996;67(2):482-489.

    Not in our library10.1046/j.1471-4159.1996.67020482.x

34. 34.

    Takeda A., Onodera H., Sugimoto A., Itoyama Y., Kogure K., Shibahara S. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res. 1994;666(1):120-124.

    Not in our library10.1016/0006-8993(94)90292-5

35. 35.

    Takeya M., Hsiao L., Takahashi K. A new monoclonal antibody, TRPM-3, binds specifically to certain rat macrophage populations: immunohistochemical and immunoelectron microscopic analysis. J Leukoc Biol. 1987;41(3):187-195.

    Not in our library10.1002/jlb.41.3.187

36. 36.

    Tenhunen R., Marver H. S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61(2):748-755.

    Not in our library10.1073/pnas.61.2.748

37. 37.

    Thomsen L. L., Lawton F. G., Knowles R. G., Beesley J. E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994;54(5):1352-1354.

    Not in our library

38. 38.

    Thomsen L. L., Scott J. M., Topley P., Knowles R. G., Keerie A. J., Frend A. J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 1997;57(15):3300-3304.

    Not in our library

39. 39.

    Tozer G. M., Prise V. E., Bell K. M. The influence of nitric oxide on tumour vascular tone. Acta Oncol. 1995;34(3):373-377.

    Not in our library10.3109/02841869509093992

40. 40.

    Tozer G. M., Prise V. E., Chaplin D. J. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res. 1997;57(5):948-955.

    Not in our library

41. 41.

    Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49(23):6449-6465.

    Not in our library

42. 42.

    Wood P. J., Sansom J. M., Butler S. A., Stratford I. J., Cole S. M., Szabo C., Thiemermann C., Adams G. E. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Cancer Res. 1994;54(24):6458-6463.

    Not in our library

43. 43.

    Wu J., Akaike T., Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res. 1998;58(1):159-165.

    Not in our library

44. 44.

    Yamasaki K., Konno T., Miyauchi Y., Maeda H. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein. Cancer Res. 1987;47(3):852-855.

    Not in our library

45. 45.

    Yet S. F., Pellacani A., Patterson C., Tan L., Folta S. C., Foster L., Lee W. S., Hsieh C. M., Perrella M. A. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem. 1997;272(7):4295-4301.

    Not in our library10.1074/jbc.272.7.4295

46. 46.

    Yoshimura T., Yokoyama H., Fujii S., Takayama F., Oikawa K., Kamada H. In vivo EPR detection and imaging of endogenous nitric oxide in lipopolysaccharide-treated mice. Nat Biotechnol. 1996;14(8):992-994.

    Not in our library10.1038/nbt0896-992

47. 47.

    Ziche M., Morbidelli L., Choudhuri R., Zhang H. T., Donnini S., Granger H. J., Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99(11):2625-2634.

    Not in our library10.1172/jci119451

Cited by papers we hold 1

• Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour · 2003
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.